Bruno Manadas is a Biochemist and received is PhD in Cell Biology from the University of Coimbra, followed by a postdoc at the Conway Institute in Ireland, dedicated to schizophrenia biomarkers. Currently he is a group leader at the Center for Neurosciences and Cell Biology, University of Coimbra. His research interests are focused on signaling and biomarkers research using either human samples or translational research involving cellular and animal models. The main areas of research are 1) identification of novel signaling pathways related with response to stimuli and neuroprotection through interactomics approaches, 2) translational biomarker research for neurodegenerative disorders, and 3) biomarker profiling of neurodegenerative and neurological disorders. He is currently author of more than 40 papers (over 1600 citations), he serves as an Associated editor in several journals, including Frontiers in Molecular Neuroscience and Journal of Integrated OMICS. He received 3 FCT projects as PI, 4 as co-PI, and is the CNC scientific PI at the National Mass Spectrometry Network. His lab was recognized as reference lab for the world leading mass spectrometry company, Sciex to develop LC-MS/MS applications in biomedicine.